Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. [electronic resource]
Producer: 19970113Description: S114-30 p. digitalISSN:- 0364-5134
- Adrenal Cortex Hormones -- therapeutic use
- Animals
- Antibodies, Antiphospholipid -- immunology
- Antibody Specificity
- Anticoagulants -- therapeutic use
- Antiphospholipid Syndrome -- complications
- Autoantigens -- immunology
- Blood Coagulation Factors -- immunology
- Blood Platelets -- immunology
- Cerebrovascular Disorders -- etiology
- Endothelium, Vascular -- immunology
- Female
- Fibrinolytic Agents -- therapeutic use
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Lupus Coagulation Inhibitor -- immunology
- Male
- Plasma Exchange
- Platelet Aggregation Inhibitors -- therapeutic use
- Thrombosis -- etiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.